We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Models Improve Mortality Risk Prediction After PCI for STEMI

By HospiMedica International staff writers
Posted on 18 Nov 2026

ST-elevation myocardial infarction (STEMI) is a heart attack caused by complete blockage of one or more coronary arteries. More...

More than 2 million people worldwide develop STEMI each year. Percutaneous coronary intervention (PCI) is effective for many patients, but mortality risk can remain high after treatment. Researchers have now developed machine-learning models to identify patients at increased risk of death after PCI.

The PERISCOPE (Patient Risk StratifiCation for Post-STEMI Complications) project, involving Amsterdam University Medical Centre, was developed to predict in-hospital and six-month mortality after percutaneous coronary intervention (PCI). The models are designed to support risk stratification after the procedure, a clinically relevant time point because existing guideline-recommended scores, including GRACE 2.0, estimate risk at presentation rather than after PCI.

The research team trained logistic regression models using the U.S. PREMIER PINC AI Healthcare Database, which included 38,489 patients. The models were then independently tested using U.S. TriNetX data from 119,035 patients and externally validated using electronic medical record data from 6,776 patients at Amsterdam UMC.

Across the three databases, in-hospital mortality rates ranged from 6.6% to 9.9%, while six-month mortality rates ranged from 11.4% to 23.7%. The PERISCOPE models outperformed the GRACE 2.0 score in predicting both in-hospital and six-month mortality across all three databases. In each comparison, the lower bound of the 95% confidence interval for the area under the receiver operating characteristic curve for PERISCOPE exceeded the upper bound observed with GRACE 2.0.

The findings were presented at the ESC Digital & AI Summit 2026. The results suggest that post-PCI machine-learning models may help identify patients who could benefit from additional treatment or closer monitoring. Further evaluation in more diverse populations and prospective studies is still needed before the models can be integrated into clinical care pathways.

“The machine-learning models provided good discrimination of both in-hospital and six-month mortality. One of the most encouraging aspects was that the models showed consistent performances across the three datasets, which were geographically and clinically diverse, suggesting good generalizability,” said Dr. Andrea Rafanelli, presenter from Amsterdam University Medical Centre.

Related Links
European Society of Cardiology
Amsterdam University Medical Centre


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Tourniquet System
heidi– mein Tourniquet
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.